Fatal arrhythmias prompt labelling update for droperidol Correspondence 09 February 2013 Pages: 2 - 2
Benefit-risk assessment: industry and regulatory perspectives Meeting report 09 February 2013 Pages: 3 - 4
Nevirapine: anti-allergic agents and female gender increase rash risk Incidence study 09 February 2013 Pages: 5 - 5
Nevirapine: risk of Stevens-Johnson syndrome or toxic epidermal necrolysis Clinical study 09 February 2013 Pages: 5 - 5
Risk of drug-related death higher for elderly patients with multiple diseases? Incidence study 09 February 2013 Pages: 5 - 5
Irinotecan plus fluorouracil/folinic acid: increased risk of death? Incidence study 09 February 2013 Pages: 6 - 6
Rofecoxib: better tolerated than other NSAIDs in patients with urticaria Clinical study 09 February 2013 Pages: 7 - 7
Thalidomide and antineoplastic therapy: increased risk of DVT Incidence study 09 February 2013 Pages: 7 - 7
